OPNT - Opiant Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 552.74M
Enterprise Value 328.97M
Trailing P/E N/A
Forward P/E 1-13.89
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.98
Price/Book (mrq)3.09
Enterprise Value/Revenue 31.63
Enterprise Value/EBITDA 6-2.11

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -76.70%
Operating Margin (ttm)-77.40%

Management Effectiveness

Return on Assets (ttm)-42.83%
Return on Equity (ttm)-119.60%

Income Statement

Revenue (ttm)17.71M
Revenue Per Share (ttm)5.32
Quarterly Revenue Growth (yoy)219.10%
Gross Profit (ttm)-9.71M
EBITDA -13.71M
Net Income Avi to Common (ttm)-13.59M
Diluted EPS (ttm)-4.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.77M
Total Cash Per Share (mrq)5.95
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.77
Book Value Per Share (mrq)4.28

Cash Flow Statement

Operating Cash Flow (ttm)-4.17M
Levered Free Cash Flow (ttm)1.11M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.33
52-Week Change 3-16.88%
S&P500 52-Week Change 34.25%
52 Week High 329.55
52 Week Low 39.98
50-Day Moving Average 311.73
200-Day Moving Average 313.59

Share Statistics

Avg Vol (3 month) 322.23k
Avg Vol (10 day) 319.1k
Shares Outstanding 54M
Float 3.07M
% Held by Insiders 118.16%
% Held by Institutions 120.17%
Shares Short (May 31, 2019) 463.25k
Short Ratio (May 31, 2019) 42.71
Short % of Float (May 31, 2019) 41.71%
Short % of Shares Outstanding (May 31, 2019) 41.58%
Shares Short (prior month Apr 30, 2019) 468.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/1
Last Split Date 3Dec 31, 2014